|Bid||20.87 x 1000|
|Ask||22.50 x 800|
|Day's Range||21.00 - 22.42|
|52 Week Range||3.67 - 38.50|
|Beta (5Y Monthly)||3.92|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Celebrations may be in order for Seres Therapeutics, Inc. ( NASDAQ:MCRB ) shareholders, with the analysts delivering a...
Today is shaping up negative for Seres Therapeutics, Inc. ( NASDAQ:MCRB ) shareholders, with the analysts delivering a...
Seres Therapeutics (MCRB) delivered earnings and revenue surprises of -18.18% and 7.83%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?